Clinical Trial Update: Study of a Novel Therapeutic Vaccine Against Hepatitis C Using Ad6NSmut and MVA-NSmut in Chronically Infected Patients [Phase 1]

View source ↗

Summary

Phase 1 study evaluating a novel Ad6NSmut/MVA-NSmut therapeutic vaccine for chronic Hepatitis C has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ad6NSmut
• MVA-NSmut

Snippet

Sponsor: ReiThera Srl | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED